
|Articles|October 1, 2003
CIBA Vision echoes Pfizer's call for surgical business buyers
Author(s)Jennifer A. Webb
Duluth, GA-Less than a month after Pfizer Inc. announced it would consider selling off the surgical business it acquired with its merger with Pharmacia Corp. (Ophthalmology Times, Sept. 1 issue, Page 3), another large manufacturer of ophthalmic surgical products has announced it is pondering selling the surgical segment of its business as well.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves veligrotug-vvze (Lumvoa) for thyroid eye disease across active and chronic stages
2
Detecting peripheral retinal lesions in children with myopia
3
FDA grants priority review to Satralizumab sBLA for thyroid eye disease
4
4DMT completes enrollment in 4FRONT-2, global phase 3 trial of 4D-150 in wet AMD
5

























